ChemicalBook >> CAS DataBase List >>Ibalizumab
Ibalizumab
- CAS No.
- 680188-33-4
- Chemical Name:
- Ibalizumab
- Synonyms
- Ibalizumab;TNX-355|||TMB-355;Ibalizumab (anti-CD4);Research Grade Ibalizumab(DHB95901)
- CBNumber:
- CB68080783
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
Last updated:2024-07-02 08:55:14
| storage temp. | Store at -20°C |
|---|---|
| form | Solid |
| color | White to off-white |
| FDA UNII | LT369U66CE |
| ATC code | J05AX23 |
Ibalizumab Chemical Properties,Uses,Production
Description
Ibalizumab (also known as ibalizumab-uiyk and formerly known as TNX-355) is a monoclonal antibody that binds to CD4 receptors on the surface of CD4-positive cells, preventing HIV particle entry into the lymphocytes.
Uses
Ibalizumab is an advanced and current antibody in development for the treatment of HIV/AIDS. It has been developed by Taimed biologics and Theratechnologies.
Ibalizumab Preparation Products And Raw materials
Raw materials
Preparation Products
Ibalizumab Suppliers
Global( 9)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Aladdin Scientific | +1-+1(833)-552-7181 | sales@aladdinsci.com | United States | 57511 | 58 |
| ShangHai Biochempartner Co.,Ltd | 17754423994 17754423994 | 2853530910@QQ.com | China | 8005 | 62 |
| Guangzhou Hongyuan Chemical Co.,Ltd | 15817493340 | 981810490@qq.com | China | 1565 | 58 |
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10022 | 58 |
| AntibodySystem | 17762345272 18162686757 | biolab-reagents@atagenix.com | China | 9817 | 58 |
| Wuhan Jingkangen Biomedical Technology Co., Ltd | 13720134139 13720134139 | orders@jknbiochem.com | China | 5371 | 58 |
| Shanghai Aladdin Biochemical Technology Co.,Ltd. | +86-18521732826 | market@aladdin-e.com | China | 48467 | 58 |
| Changsha Fuzhen Biotechnology Co.，LTD | 0731-18670069 18670069958 | 184792226@qq.com | China | 3195 | 58 |
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 28091 | 58 |
Ibalizumab
Research Grade Ibalizumab(DHB95901)
Ibalizumab (anti-CD4)
TNX-355|||TMB-355
680188-33-4